E2F1 modulates cell death via activation of proapoptotic genes and by inactivation of antiapoptotic survival factors through p53-dependent or p53-independent pathways [34] that is consistent with the current results as DLBCL cases with numerous apoptosis belonged to high E2F1 expression. The gene discussed is TP53; the disease is diffuse large B-cell lymphoma.